ClinicalTrials.Veeva

Menu

Omega-3 Fatty Acids as Adjunctive Treatment for Adolescents With Eating Disorders

McMaster University logo

McMaster University

Status

Completed

Conditions

Eating Disorder

Treatments

Dietary Supplement: Omega-3 Fatty Acid Supplement

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Eating disorders are conditions that are defined by abnormal eating habits that involve insufficient or excessive food intake. With regards to treating these disorders, there is an increasing interest in fat deprivation due to a lack of proper diet, particularly dietary fats such as polyunsaturated fatty acids. These fatty acids are essential components of the brain and are important for normal functioning of the body. Since the body cannot synthesize these fats, it has to rely completely on diet to obtain a sufficient amount. Hence, diets that lack sufficient fats or under fasting conditions, the imbalance of these fats can severely alter brain functions. The investigators want to see if these supplements are well tolerated and accepted by adolescent patients with eating disorders.

Enrollment

21 patients

Sex

All

Ages

Under 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diagnosis of Eating Disorder, less than 18 years of age

Exclusion criteria

  • unable to read and understand English

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

21 participants in 1 patient group

Omega-3 Fatty Acid Supplement
Experimental group
Treatment:
Dietary Supplement: Omega-3 Fatty Acid Supplement

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems